At a time when the credit rating industry has been subdued due to low growth in debt and credit markets, CARE Ratings has delivered an impressive performance. DR Dogra, MD and CEO of CARE Ratings, says that the company has delivered a 39 per cent increase in income from operations and a 28 per cent growth in bottomline. There has been a 30 per cent growth in new assignments and thereby the net profit margin has been maintained. The company has also jacked up the dividend payout on completing 20 years of successful operations, he says. CARE Ratings is now looking at inorganic growth overseas in markets like Brazil, Portugal etc.